Mesoblast (MESO) Net Income towards Common Stockholders (2014 - 2023)

Mesoblast has reported Net Income towards Common Stockholders for 10 years, with the latest figure at -$21.9 million in Q2 2023.

• Quarterly Net Income towards Common Stockholders fell 2.16% year-over-year to -$21.9 million in Q2 2023, while the trailing twelve-month figure through Dec 2024 was -$21.9 million (up 66.28% YoY) and the FY2025 annual result came in at -$102.1 million, down 16.13% from the prior year.
• Net Income towards Common Stockholders eased to -$21.9 million in Q2 2023 per MESO's latest filing, from -$18.6 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at -$5.5 million in Q3 2019 and troughed at -$32.6 million in Q2 2020.
• A 5-year average of -$22.0 million and a median of -$22.4 million in 2021 frame the typical range for Net Income towards Common Stockholders.
• The sharpest annual moves came in 2019 and 2020: Net Income towards Common Stockholders jumped 71.87% in 2019, then tumbled 347.56% in 2020.
• Over 5 years, Net Income towards Common Stockholders stood at -$24.6 million in 2019, then fell by 4.51% to -$25.7 million in 2020, then dropped by 0.98% to -$25.9 million in 2021, then advanced by 5.62% to -$24.5 million in 2022, then increased by 10.48% to -$21.9 million in 2023.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$21.9 million, -$18.6 million, and -$24.5 million for Q2 2023, Q1 2023, and Q4 2022 respectively.